Atlas Trials

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Clinical trial NCT01896232 · COMPLETED

Trial details

NCT number
NCT01896232
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary HyperparathyroidismChronic Kidney Disease
Start date
2013-08-13
Primary completion
2014-11-12
Enrollment
683

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.